NEW YORK, Sept. 27, 2023 /PRNewswire/ — The “baking ingredients market by product (flour, yeast ingredients, fats and shortening, sweeteners, and others), application (bread, cookies and biscuits, cakes and pastries, and others), and geography (Europe, APAC, North America, Middle East…
Month: September 2023
Akeso Announced FDA Clearance of IND for CD47 Monoclonal Antibody (AK117) in Combination with Azacitidine in Myelodysplastic Syndromes
HONG KONG, Sept. 27, 2023 /PRNewswire/ — Akeso, Inc. (the Company, Akeso, 9926.HK) announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for AK117, a next generation CD47 monoclonal antibody in combination with…
Rising Demand for Miniaturized Electronics and Sustainable Transportation Boosts Advanced Polymer Composites Market
DUBLIN, Sept. 27, 2023 /PRNewswire/ — The “Global Advanced Polymer Composites Market Report and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global advanced polymer composites market reached approximately USD 18.84 billion in 2022 and is expected to…
Rapid Growth Of Vacation Rentals Bookings In Asia Is Confirmed
Trip101 expects an 84% jump in vacation rentals bookings in Asia from 2022 to 2023. Longer stays by travelers in Asia are also confirmed. Average length of stay has grown by 20% since pre-pandemic times. SINGAPORE, Sept. 27, 2023 /PRNewswire/ — Global travel media startup Trip101, which…
REMOTE GUARDING IS A BOON FOR CLOUDASTRUCTURE
Cloudastructure releases Q3 Remote Guarding statistics MIAMI, Sept. 27, 2023 /PRNewswire/ — Today, Cloudastructure released Q3 statistics for their award-winning integrated Remote Guarding software and global guard services and the results are impressive. With a full quarter of the…
BioCity Signs Collaboration Agreement with AstraZeneca on BC3402, a monoclonal antibody targeting anti-TIM-3, in Combination with IMFINZI (durvalumab) for the Treatment of Advanced Hepatocellular Carcinoma in China
WUXI, China, Sept. 27, 2023 /PRNewswire/ — September 25th, 2023, BioCity Biopharma and AstraZeneca signed an agreement to collaborate on a Phase Ib/II clinical study to evaluate the safety and efficacy of BioCity’s BC3402, a monoclonal antibody (mAb) targeting the T cell immunoglobulin…
BioCity Signs Collaboration Agreement with AstraZeneca on BC3402, a monoclonal antibody targeting anti-TIM-3, in Combination with IMFINZI (durvalumab) for the Treatment of Advanced Hepatocellular Carcinoma in China
WUXI, China, Sept. 27, 2023 /PRNewswire/ — September 25th, 2023, BioCity Biopharma and AstraZeneca signed an agreement to collaborate on a Phase Ib/II clinical study to evaluate the safety and efficacy of BioCity’s BC3402, a monoclonal antibody (mAb) targeting the T cell immunoglobulin…
ESG Considerations Gain Importance in the Growing Global Abrasives Market: 2023 Report
DUBLIN, Sept. 27, 2023 /PRNewswire/ — The “Global Abrasive Market: Materials, Products, and Applications” report has been added to ResearchAndMarkets.com’s offering. The global abrasives market is expected to reach $74 billion in 2028 from $57.8 billion in 2023 at a CAGR of 5.1%. The…
ESG Considerations Gain Importance in the Growing Global Abrasives Market: 2023 Report
DUBLIN, Sept. 27, 2023 /PRNewswire/ — The “Global Abrasive Market: Materials, Products, and Applications” report has been added to ResearchAndMarkets.com’s offering. The global abrasives market is expected to reach $74 billion in 2028 from $57.8 billion in 2023 at a CAGR of 5.1%. The…
Stellus Private Credit BDC Announces $0.46 Third Quarter 2023 Regular Dividends
HOUSTON, Sept. 27, 2023 /PRNewswire/ — Stellus Private Credit BDC (“the Company”) announced that its Board of Trustees has declared a dividend of $0.46 for the third quarter of 2023. The regular dividend of $0.46 per share will be paid on October 6, 2023 to shareholders of record on…
